trending Market Intelligence /marketintelligence/en/news-insights/trending/porf_sp6y62-qn8r8acrwg2 content esgSubNav
In This List

Acasti Pharma appoints chief commercial officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Acasti Pharma appoints chief commercial officer

Canadian biopharmaceutical company Acasti Pharma Inc. appointed Brian Groch as chief commercial officer.

Groch was most recently the executive vice president and chief commercial officer of Veru Inc., where he helped grow the sales of the company's women's health product, Acasti said.

At Acasti, Groch will be responsible for helping the company with the global commercial planning and market development of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, a chronic condition affecting an estimated one-third of the U.S. population.

CaPre is undergoing a late-stage clinical trial.